Skip to main content
Top menu
Easy to read
Sitemap
lv
en
Toggle navigation
Main navigation
Home
Legislation
About Us
About the agency
Strategy
History
Structure
Director
Statute and regulations
Code of ethics
International cooperation
Projects
Property
Quality policy
Annual Report
Processing of personal data
State Agency of Medicines’ Statement on Cookie Policy
Request for personal data processing
Publications and statistics
News
Publications and statistics
Bulletin “Cito!”
Drug Register of the Republic of Latvia
Book “Introduction in Pharmacovigilance”
Statistics on Medicines Consumption
Baltic Statistics on Medicines
Antimicrobial consumption database
Statistics on Medicines Consumption (DDD)
Contacts
Sekundārā izvēlne
Patients and Public
Medicines
Purchase of medicines in pharmacy
Online pharmacies
Use and storage of medicines
Carrying medicines into and out of the country and receiving them by post
Medicines in specific cases
Clinical trials
Clinical Trial Register
Covid-19 vaccines
Medical devices
Clinical investigations and Performance studies
Blood, tissue, cells, organs
List of authorised institutions
Healthcare professionals and institutions
Medicines
Pilot project for Electronic Package Information Leaflets (e-PIL)
Licenced pharmaceutical activity companies
Clinical trials
Contract research organizations
Clinical Trial Register
Good Clinical Practice
Pharmacovigilance
Risk minimization educational materials
Black triangle
Bulletin “Cito!”
Statistics of adverse drug reaction reports
Book “Introduction in Pharmacovigilance”
List of substances
List of pharmaceutical terms
ATC classification
Medical devices
Vigilance
Clinical investigations and Performance studies
Blood, tissue, cells, organs
Compliance assessment
List of authorised institutions
Industry
Marketing authorisation holders
Pre-authorisation
Decentralised procedure
Mutual recognition procedure
National procedure
Centralised procedure
Authorisation procedure with Latvia as reference member state
Medicinal products available for compassionate use
Post-authorisation
Transfer of Marketing Authorisation Holder
Notifications regarding start of distribution, supply disruptions and price of medicinal products
Gift of medicinal products
Multilingual packaging
Foreign country packaging in Latvia
Leaving the market
Requirements for quality control of medicines (including vaccines)
Pharmacovigilance
News
Risk minimization educational materials
Direct healthcare professional communications
Black triangle
Reporting of adverse drug reactions
Information regarding marketing authorisation, renewal and withdrawal of marketing authorisation of medicines
Purchase of statistical data
Variations to marketing authorisation documentation (announcements)
Cost-effectivenes assessment
Information on the granting of exemptions from the Sunset Clause
Up-to-date information on the decisions made by the Agency of the granting of exemptions from the Sunset Clause
Evaluation of compliance of a product with the definition of a medicinal product
Scientific Advice
Frequently asked questions (FAQ)
Pharmacies
New pharmacy
Medicinal Product Register in XML format
Manufacturers of medicines
Manufacturer operation
Medicines export certificates
Free Sales Certificate
Certificate of Pharmaceutical Product
Statement of Product Registration Status
Permissions
Purchase of statistical data
Manufacturers, importers and distributors of active substances
Medicines export certificates
Free Sales Certificate
Certificate of Pharmaceutical Product
Statement of Product Registration Status
Permissions
Purchase of statistical data
Wholesalers and brokers
New wholesaler
Brokers (brokering of medicinal products)
List of marketing authorization holders
Parallel Distribution of Medicinal Products
Parallel Imported Medicinal Products
Recognition of special authorisations (licences) issued in the EU or EEA State for the type of business concerned
Requirements for quality control of medicines (including vaccines)
Sponsors of clinical trials
Clinical Trials Regulation
Ethics committee
Safety reports
Contract research organizations
Non-interventional trials
GDPR
Medical device manufacturers, authorized representatives
Before being placed on market
Latmed
Clinical investigations and Performance studies
Vigilance
Precursor operators
Substances controlled in Latvia in research and training
Search
Sekundārā izvēlne
Patients and Public
Medicines
Purchase of medicines in pharmacy
Online pharmacies
Use and storage of medicines
Carrying medicines into and out of the country and receiving them by post
Medicines in specific cases
Clinical trials
Clinical Trial Register
Covid-19 vaccines
Medical devices
Clinical investigations and Performance studies
Blood, tissue, cells, organs
List of authorised institutions
Healthcare professionals and institutions
Medicines
Pilot project for Electronic Package Information Leaflets (e-PIL)
Licenced pharmaceutical activity companies
Clinical trials
Contract research organizations
Clinical Trial Register
Good Clinical Practice
Pharmacovigilance
Risk minimization educational materials
Black triangle
Bulletin “Cito!”
Statistics of adverse drug reaction reports
Book “Introduction in Pharmacovigilance”
List of substances
List of pharmaceutical terms
ATC classification
Medical devices
Vigilance
Clinical investigations and Performance studies
Blood, tissue, cells, organs
Compliance assessment
List of authorised institutions
Industry
Marketing authorisation holders
Pre-authorisation
Decentralised procedure
Mutual recognition procedure
National procedure
Centralised procedure
Authorisation procedure with Latvia as reference member state
Medicinal products available for compassionate use
Post-authorisation
Transfer of Marketing Authorisation Holder
Notifications regarding start of distribution, supply disruptions and price of medicinal products
Gift of medicinal products
Multilingual packaging
Foreign country packaging in Latvia
Leaving the market
Requirements for quality control of medicines (including vaccines)
Pharmacovigilance
News
Risk minimization educational materials
Direct healthcare professional communications
Black triangle
Reporting of adverse drug reactions
Information regarding marketing authorisation, renewal and withdrawal of marketing authorisation of medicines
Purchase of statistical data
Variations to marketing authorisation documentation (announcements)
Cost-effectivenes assessment
Information on the granting of exemptions from the Sunset Clause
Up-to-date information on the decisions made by the Agency of the granting of exemptions from the Sunset Clause
Evaluation of compliance of a product with the definition of a medicinal product
Scientific Advice
Frequently asked questions (FAQ)
Pharmacies
New pharmacy
Medicinal Product Register in XML format
Manufacturers of medicines
Manufacturer operation
Medicines export certificates
Free Sales Certificate
Certificate of Pharmaceutical Product
Statement of Product Registration Status
Permissions
Purchase of statistical data
Manufacturers, importers and distributors of active substances
Medicines export certificates
Free Sales Certificate
Certificate of Pharmaceutical Product
Statement of Product Registration Status
Permissions
Purchase of statistical data
Wholesalers and brokers
New wholesaler
Brokers (brokering of medicinal products)
List of marketing authorization holders
Parallel Distribution of Medicinal Products
Parallel Imported Medicinal Products
Recognition of special authorisations (licences) issued in the EU or EEA State for the type of business concerned
Requirements for quality control of medicines (including vaccines)
Sponsors of clinical trials
Clinical Trials Regulation
Ethics committee
Safety reports
Contract research organizations
Non-interventional trials
GDPR
Medical device manufacturers, authorized representatives
Before being placed on market
Latmed
Clinical investigations and Performance studies
Vigilance
Precursor operators
Substances controlled in Latvia in research and training
Breadcrumb
Home
DIRECTOR
Medicines Marketing Authorization Department
Pharmacovigilance Division
Medicinal product register
Report adverse drug reactions and incidents with medical devices
Pharmacy map
Medicines shortages
Patients and Public
Healthcare professionals and institutions
Industry
Pharmacovigilance Division
